| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
62,039
|
59,604
|
73,919
|
63,838
| | Cost of Revenue | 26,065 | 30,325 | 30,859 | 26,033 | | |
Gross Profit
|
35,974
|
29,279
|
43,060
|
37,805
| |
|
Operating Expenses |
|
Research Development | 18,558 | 17,305 | 17,848 | 20,512 |
|
Selling General and Administrative | 16,402 | 12,279 | 14,834 | 14,196 |
|
Non Recurring | (7) | (54) | 73 | 86 |
|
Others | 251 | (889) | 496 | 496 |
|
|
|
Total Operating Expenses | 35,204 | 28,641 | 33,251 | 35,290 | | | |
Operating Income or Loss
|
770
|
638
|
9,809
|
2,515
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 391 | (8,573) | 323 | 245 |
|
Earnings Before Interest And Taxes | 1,161 | (6,274) | 10,132 | 2,760 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 1,161 | (6,274) | 10,132 | 2,760 |
|
Income Tax Expense | 1,742 | 1,458 | 2,464 | 3,109 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (581) | (265) | (408) | (943) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(581)
|
(265)
|
(408)
|
(943)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(581)
|
(265)
|
(408)
|
(943)
|
|
0.21(3.53%) 2:33PM EDT - Nasdaq Real Time Price